Connect your AI

Eton Pharmaceuticals, Inc. ETON Price / book

Price / book at other companies

HRO

HarrowHROW

45.7×+28.9×

Zevra Therapeutics, Inc.ZVRA

2.7×-7.2×

XER

Xeris Biopharma Holdings, Inc.XERS

76.9×—

Ultragenyx PharmaceuticalRARE

316.5×+303×

ANI PharmaceuticalsANIP

3.1×-0.4×

Crinetics PharmaceuticalsCRNX

3×+0.5×

Other financials

Income statement

Revenue$24.3M+40.4%

Gross profit$14.7M+49.4%

Operating income$2.4M+614%

Net income$1.6M+199%

EPS (diluted)$0.05+183%

Balance sheet

Cash & equivalents$19.7M+12.9%

Total debt$31.3M+3.7%

Total equity$30.6M+25.2%

Total assets$97.7M+16.3%

Cash flow

Operating cash flow$7.4M+254%

CapEx$75.0K—

Free cash flow$7.3M+251%

Valuation

Market cap$930.79M+156%

Enterprise value$942.39M+150%

P/S10.7×+3.2×

Profitability

Gross margin54.8%-3.7pp

Operating margin-15.1%—

Net margin-9.5%-2.7pp

FCF margin17.1%—

Returns & leverage

Return on equity-34.2%+0.9pp

Debt / equity1×-0.2×

Current ratio1.2×-0.8×

Where this comes from

Calculated from Eton Pharmaceuticals, Inc.’s reported figures.

market cap/total stockholders equity=22×

Based on the most recent quarter.

The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eton Pharmaceuticals, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Eton Pharmaceuticals, Inc.'s price / book?: Eton Pharmaceuticals, Inc. (ETON) reported price / book of 22× in Q1 2026.
How has Eton Pharmaceuticals, Inc.'s price / book changed year-over-year?: Eton Pharmaceuticals, Inc.'s price / book increased by 54.5% year-over-year, from 14.2× to 22×.
What is the long-term trend for Eton Pharmaceuticals, Inc.'s price / book?: Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s price / book has grown at a 8.9% compound annual growth rate (CAGR), from 11.3× to 17.3×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.